What Bell's palsy is, and how most cases end
Bell's palsy is a sudden weakness or paralysis of the muscles on one side of the face, caused by inflammation of the facial nerve. It arrives quickly, often overnight, and it is frightening in a way few other benign conditions are, because the face is where identity lives. The first clinical priority is always to exclude stroke and other serious causes, which is why sudden facial weakness is an emergency until proven otherwise.
The natural history is genuinely reassuring. The majority of people recover completely, most within three to four months, and early treatment improves those odds further. The standard of care in the UK, reflected in NICE clinical knowledge summaries, is a course of oral corticosteroids started within 72 hours of onset, alongside scrupulous eye protection while the blink is weak, because an eye that cannot close properly is at real risk of corneal damage.
A minority, however, do not recover cleanly. Estimates vary by study and severity, but a meaningful proportion of patients are left with residual weakness, tightness, or a phenomenon called synkinesis. This group is the only group for whom aesthetic medicine has anything legitimate to offer, and everything that follows in this article concerns them.
Why the NHS pathway comes first
This point deserves its own section because the sequencing matters clinically, not just administratively. In the acute phase, the priorities are steroids, eye care and exclusion of other diagnoses. None of these is an aesthetic service. A private aesthetic clinic that offers to treat a recent-onset facial palsy is advertising a misunderstanding of the condition.
Beyond the acute phase, the NHS offers facial therapy, sometimes called facial neuromuscular retraining, delivered by specialist physiotherapists and speech and language therapists. For patients with significant residual palsy, referral to a specialist facial palsy service, often multidisciplinary and hospital-based, is the appropriate route, and several such services exist across the UK. These teams use botulinum toxin themselves, on the NHS, for exactly the indications discussed below.
The private aesthetic sector enters the picture in two circumstances: where NHS access is slow or geographically difficult, and where a patient discharged from NHS care wants ongoing maintenance treatment. Both are legitimate. Neither replaces the pathway, and any private practitioner worth seeing will want to know what NHS assessment has already happened, and will communicate with the patient's GP.
Synkinesis: the problem that persists
When a damaged facial nerve regrows, its fibres do not always find their original destinations. The result is synkinesis: involuntary movement in one part of the face triggered by voluntary movement in another. The classic patterns include the eye narrowing or closing when the patient smiles, the corner of the mouth pulling when they blink, and a chronically tight, over-recruited cheek or neck.
Synkinesis is not weakness. It is miswiring, and this distinction shapes treatment. Strengthening exercises aimed at the wrong muscles can make it worse, which is one of several reasons that generic facial exercises found online are a poor idea for this group. The evidence-supported approach combines specialist facial therapy to retrain movement patterns with targeted chemodenervation, which is where botulinum toxin comes in.
Synkinesis is not weakness, it is miswiring, and treating it as weakness makes it worse.
It is also worth naming the psychological weight. Facial difference affects social confidence, employment and mood, and research on facial palsy consistently records elevated rates of anxiety and low mood in those with persistent symptoms. A practitioner who treats the muscle and ignores the person is doing half the job.
What botulinum toxin can do here
Botulinum toxin is the single most useful aesthetic-medicine tool in post-palsy care, and its use here is quite different from cosmetic wrinkle treatment. The aim is functional: to quieten specific over-active or mis-wired muscles so that the face moves in a more coordinated, more symmetrical way.
Typical targets include the orbicularis oculi where the eye screws up during smiling, the platysma where neck banding co-contracts with mouth movement, the mentalis and depressor muscles where the chin dimples or pulls, and sometimes the contralateral side, discussed below. Doses are small, placement is precise, and the effect is temporary, lasting roughly three to four months, which means treatment is a repeating commitment rather than a one-off fix.
The evidence base, summarised across the peer-reviewed literature indexed on PubMed, is supportive: studies of toxin for synkinesis consistently report improvement in facial symmetry scores and patient-reported quality of life, particularly when combined with facial therapy. The limitations should be stated plainly. Trials are mostly small, protocols and dosing vary between centres, and there is no single agreed injection map, which means outcomes depend heavily on the individual assessor. This is a field where the practitioner is the variable that matters most.
Two practical points. First, botulinum toxin is a prescription-only medicine, so a face-to-face consultation with a qualified prescriber is a legal requirement, not a courtesy. Second, in facial palsy the margin for error is smaller than in cosmetic work: an over-treated muscle in an already weakened face can cost function the patient cannot spare.
Symmetry work on the unaffected side
One of the less intuitive strategies is treating the healthy side. When one side of the face is weak, the unaffected side often over-pulls, dragging the mouth and deepening lines asymmetrically, especially during expression. Small doses of toxin on the strong side can rebalance the smile and soften the asymmetry that patients often find most distressing in photographs.
Filler and biostimulatory treatments occasionally have a supporting role, for instance where long-standing palsy has led to volume and tissue changes on the affected side, but the evidence here is thinner and the risks are real: injecting into a face with altered anatomy and altered animation demands genuine expertise. The same cautious framing we applied to regenerative injectables generally applies doubly in a post-palsy face. Plausible is not proven, and a patient in this group has more to lose from an avoidable complication.
Choosing a practitioner for facial palsy work
This is not a treatment to buy from a price list. The practitioners who do this work well tend to share identifiable features, and patients are entitled to check every one of them.
- They are regulated healthcare professionals, verifiable on the GMC register or the equivalent NMC or GDC registers
- They can describe specific experience with facial palsy patients, not just cosmetic toxin experience, and will say how many such patients they treat
- They assess the whole face in motion, on video or through repeated expression, before proposing any injection points
- They work alongside, or will refer to, facial therapy rather than presenting toxin as a standalone answer
- They write to the GP and keep proper records, because this is medical care, not a beauty service
A small number of practices around the UK, including some in London, in areas such as Chiswick, have built genuine experience with facial palsy patients alongside their cosmetic work. That experience is worth seeking out, but it must be verified rather than assumed, and our guide to what clinic labels do and do not mean in UK law explains why the checking falls to the patient. Costs for this work vary in the same way all injectable pricing does, for reasons covered in our UK pricing review, but cost should be the last filter applied here, not the first.
Recovery is rarely handled by one discipline alone. Practices that combine facial assessment with injectable technique, such as Dr Harry Clinic in Chiswick, tend to treat asymmetry as a functional problem first and an aesthetic one second, which is the order that matters here.
What aesthetic medicine cannot fix
Stating the limits clearly is part of treating this group with respect. Toxin does not restore movement to a paralysed muscle, it only quietens over-active ones. It does not repair the nerve. It wears off, indefinitely, every few months. For complete or near-complete palsy with no recovery, the relevant conversations are surgical, including nerve transfers and dynamic reanimation procedures, and they belong with specialist reconstructive teams, not aesthetic clinics.
The right framing for aesthetic medicine in Bell's palsy recovery is a supporting role in the late chapter of a medical story: useful, evidence-supported for synkinesis, meaningfully improving quality of life for the right patients, and safe only in experienced hands. Any clinic that presents it as more than that has told you something useful about itself.
